Searched over 200M research papers
10 papers analyzed
These studies suggest that taking vitamin B6 and B12 together can lower homocysteine levels and stroke risk but may not significantly affect cardiovascular disease risk, cognitive function, or cancer outcomes.
20 papers analyzed
Vitamin B6 (pyridoxine) and Vitamin B12 (cobalamin) are essential nutrients that play crucial roles in various bodily functions, including metabolism, red blood cell formation, and neurological health. Given their importance, many people consider taking these vitamins together as supplements. This article explores the combined effects of Vitamin B6 and B12 supplementation based on recent research findings.
Several studies have investigated the impact of combined Vitamin B6 and B12 supplementation on cardiovascular health. One significant finding is that this combination can effectively reduce homocysteine levels, a known risk factor for cardiovascular diseases. For instance, a study involving women at increased risk of cardiovascular disease found that long-term supplementation with folic acid, Vitamin B6, and Vitamin B12 reduced homocysteine concentrations by 18%. Another meta-analysis confirmed that combined B vitamin supplementation could lower homocysteine levels by 2.53 µmol/L.
Despite the reduction in homocysteine levels, the combined supplementation of Vitamin B6 and B12 does not significantly impact the incidence of cardiovascular disease events or myocardial infarction. However, it has been shown to reduce the risk of stroke. Meta-analyses have demonstrated that combined B vitamin supplementation can lower the risk of stroke by 12-14% .
The relationship between B vitamins and cognitive function has been extensively studied. A systematic review and meta-analysis found no significant evidence that Vitamin B6 or B12 supplementation improves cognitive function or slows cognitive decline in older adults. Another meta-analysis echoed these findings, showing no substantial benefit of B vitamin supplementation on cognitive outcomes.
Dietary intake of Vitamin B6 and B12 has been associated with a reduced risk of depression, particularly in females. A meta-analysis found that higher dietary intake of these vitamins was inversely associated with depression risk, with significant effects observed in women.
Research on the association between Vitamin B6, B12, and cancer risk has yielded mixed results. A dose-response meta-analysis indicated that higher serum levels of the active form of Vitamin B6 (pyridoxal 5'-phosphate) might be inversely associated with breast cancer risk, especially among postmenopausal women. However, no significant association was found for dietary Vitamin B12 intake.
In cancer patients, Vitamin B12 supplementation has shown some promise in alleviating chemotherapy-induced peripheral neuropathy. However, the overall evidence is limited, and the effectiveness of combined B vitamin supplementation in reducing chemotherapy side effects remains inconclusive.
Taking Vitamin B6 and B12 together can be beneficial in certain contexts, such as reducing homocysteine levels and lowering the risk of stroke. However, their combined supplementation does not significantly impact the incidence of cardiovascular disease events, myocardial infarction, or cognitive decline. While there is some evidence suggesting a potential benefit in reducing depression risk and alleviating chemotherapy side effects, more research is needed to confirm these findings. As always, it is advisable to consult with a healthcare provider before starting any new supplement regimen.
Most relevant research papers on this topic